Research Article
Green Synthesis of Silver Nanoparticles Using Extracts of Ehretia cymosa and Evaluation of Its Antibacterial Activity in Cream and Ointment Drug Delivery Systems
Table 5
The zone of inhibition (mm) obtained with different concentrations of the E. cymosa for the crude extracts and silver nanoparticles loaded cream formulations.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Note. CB: cream base (negative control), ACC1, ACC2, and ACC3: 1%, 1.5%, and 2% aqueous crude extract cream, respectively, MCC1, MCC2, and MCC3: 1%, 1.5%, and 2% methanol crude extract cream, respectively, ASC1, ASC2 and ASC3: 1%, 1.5%, and 2% aqueous SNPs cream, respectively, MSC1, MSC2, and MSC3: 1%, 1.5%, and 2% methanol SNPs cream, respectively, and CC: 1% ciprofloxacin cream (positive control). |